ISPAD Clinical Practice Consensus Guidelines 2018: Insulin treatment in children and adolescents with diabetes
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Refined recommendations on intensive regimens for differential substitution of basal and prandial insulin. Review of the role of new insulin analogs, biosimilars and devices for insulin therapy in pediatric diabetology are included. This article is protected by copyright. All rights reserved.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Basal insulin and cardiovascular and other outcomes in dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203858 · Cited by 1,636
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
Currie, C. J., Poole, C. D., & Gale, E. A. M. (2009) · Diabetologia · doi:10.1007/s00125-009-1440-6 · Cited by 1,124
Lepore, M., Pampanelli, S., Fanelli, C., Porcellati, F., Bartocci, L., Di Vincenzo, A., Cordoni, C., Costa, E., Brunetti, P., & Bolli, G. B. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2142 · Cited by 818
Kurtzhals, P., Schäffer, L., Sørensen, A., Kristensen, C., Jonassen, I., Schmid, C., & Trüb, T. (2000) · Diabetes · doi:10.2337/diabetes.49.6.999 · Cited by 739
Long-term effect of diabetes and its treatment on cognitive function
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa066397 · Cited by 646
Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes
Bergenstal, R. M., Garg, S., Weinzimer, S. A., Buckingham, B. A., Bode, B. W., Tamborlane, W. V., & Kaufman, F. R. (2016) · JAMA · doi:10.1001/jama.2016.11708 · Cited by 644
Self-citationHeise, T., Nosek, L., Rønn, B. B., Endahl, L., Heinemann, L., Kapitza, C., & Draeger, E. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1614 · Cited by 614
Hemkens, L. G., Grouven, U., Bender, R., Günster, C., Gutschmidt, S., Selke, G. W., & Sawicki, P. T. (2009) · Diabetologia · doi:10.1007/s00125-009-1418-4 · Cited by 607
Garg, S. K., Weinzimer, S. A., Tamborlane, W. V., Buckingham, B. A., Bode, B. W., Bailey, T. S., Brazg, R. L., Ilany, J., Slover, R. H., Anderson, S. M., et al. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0421 · Cited by 585
Self-citationthe SWITCH Study Group, Battelino, T., Conget, I., Olsen, B., Schütz-Fuhrmann, I., Hommel, E., Hoogma, R., Schierloh, U., Sulli, N., & Bolinder, J. (2012) · Diabetologia · doi:10.1007/s00125-012-2708-9 · Cited by 494
Self-citationRatner, R. E., Hirsch, I. B., Neifing, J. L., Garg, S. K., Mecca, T. E., & Wilson, C. A. (2000) · Diabetes Care · doi:10.2337/diacare.23.5.639 · Cited by 455
Karges, B., Schwandt, A., Heidtmann, B., Kordonouri, O., Binder, E., Schierloh, U., Boettcher, C., Kapellen, T., Rosenbauer, J., & Holl, R. W. (2017) · JAMA · doi:10.1001/jama.2017.13994 · Cited by 452 · cited 1×
“There was no significant difference in body mass index between both treatment regimens.(169) A literature review found an increased risk of DKA in pediatric pump patients in some studies.”
ResultJonasson, J. M., Ljung, R., Talbäck, M., Haglund, B., Gudbjörnsdòttir, S., & Steineck, G. (2009) · Diabetologia · doi:10.1007/s00125-009-1444-2 · Cited by 412
Hermansen, K., Fontaine, P., Kukolja, K. K., Peterkova, V., Leth, G., & Gall, M.-A. (2004) · Diabetologia · doi:10.1007/s00125-004-1365-z · Cited by 365
Vague, P., Selam, J.-L., Skeie, S., De Leeuw, I., Elte, J. W. F., Haahr, H., Kristensen, A., & Draeger, E. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.590 · Cited by 294
New insulin delivery recommendations
Frid, A. H., Kreugel, G., Grassi, G., Halimi, S., Hicks, D., Hirsch, L. J., Smith, M. J., Wellhoener, R., Bode, B. W., Hirsch, I. B., et al. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.06.010 · Cited by 286 · cited 3×
“Current injection recommendations for patients with diabetes have been summarized.(127)”
BackgroundMudaliar, S. R., Lindberg, F. A., Joyce, M., Beerdsen, P., Strange, P., Lin, A., & Henry, R. R. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1501 · Cited by 276
Mathieu, C., Hollander, P., Miranda-Palma, B., Cooper, J., Franek, E., Russell-Jones, D., Larsen, J., Tamer, S. C., Bain, S. C., & on behalf of the NN1250-3770 (BEGIN: Flex T1) Trial Investigators (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3249 · Cited by 219
Home, P. D. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01580.x · Cited by 212
Female reproduction and type 1 diabetes: From mechanisms to clinical findings
Codner, E., Merino, P. M., & Tena-Sempere, M. (2012) · Human Reproduction Update · doi:10.1093/humupd/dms024 · Cited by 182 · cited 2×
“to identify possible cyclical variation in blood glucose that might require clinician review and insulin dosage adjustment.(207,208) • It has been observed that an excessive GH secretion in type 1 dia-”
BackgroundHeise, T., Pieber, T. R., Danne, T., Erichsen, L., & Haahr, H. (2017) · Clinical Pharmacokinetics · doi:10.1007/s40262-017-0514-8 · Cited by 182
Self-citationRussell-Jones, D., Bode, B. W., De Block, C., Franek, E., Heller, S. R., Mathieu, C., Philis-Tsimikas, A., Rose, L., Woo, V. C., Østerskov, A. B., et al. (2017) · Diabetes Care · doi:10.2337/dc16-1771 · Cited by 177
Danne, T., Lüpke, K., Walte, K., von Schuetz, W., & Gall, M.-A. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3087 · Cited by 153
Self-citationBode, B., Weinstein, R., Bell, D., McGill, J., Nadeau, D., Raskin, P., Davidson, J., Henry, R., Huang, W.-C., & Reinhardt, R. R. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.439 · Cited by 148
Hanas, R., Lindgren, F., & Lindblad, B. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00441.x · Cited by 129 · cited 4×
“Rates of hypoglycemia did not differ significantly between the two treatment groups; however, hyperglycemia with ketosis was significantly reduced in those treated with degludec, potentially offering a particular benefit for patients prone to DKA.85”
BackgroundInfluentialInsulin Analogs Versus Human Insulin in the Treatment of Patients With Diabetic Ketoacidosis
Umpierrez, G. E., Jones, S., Smiley, D., Mulligan, P., Keyler, T., Temponi, A., Semakula, C., Umpierrez, D., Peng, L., Cerón, M., et al. (2009) · Diabetes Care · doi:10.2337/dc09-0169 · Cited by 120
Bolli, G. B., Kerr, D., Thomas, R., Torlone, E., Sola-Gazagnes, A., Vitacolonna, E., Selam, J. L., & Home, P. D. (2009) · Diabetes Care · doi:10.2337/dc08-1874 · Cited by 119
Bode, B. W., McGill, J. B., Lorber, D. L., Gross, J. L., Chang, P.-C., Bregman, D. B., & for the Affinity 1 Study Group (2015) · Diabetes Care · doi:10.2337/dc15-0075 · Cited by 114 · cited 2×
“An inhaled form of human insulin (Afrezza) has been approved as prandial insulin for adults in the United States.24”
BackgroundPaterson, M. A., Smart, C. E. M., Lopez, P. E., McElduff, P., Attia, J., Morbey, C., & King, B. R. (2016) · Diabetic Medicine · doi:10.1111/dme.13011 · Cited by 111 · cited 1×
“ies have found a lower need of insulin for protein, around 200 kcal equaling 10 g of carbs.(212) • Correction doses (also called insulin sensitivity factor, correction factor) can be used according to the “1800 rule,” that is, divide”
MethodDurability of Insulin Pump Use in Pediatric Patients With Type 1 Diabetes
Wood, J. R., Moreland, E. C., Volkening, L. K., Svoren, B. M., Butler, D. A., & Laffel, L. M. B. (2006) · Diabetes Care · doi:10.2337/dc06-1141 · Cited by 98
van Bon, A. C., Bode, B. W., Sert-Langeron, C., DeVries, J. H., & Charpentier, G. (2011) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2010.0224 · Cited by 96
Thalange, N., Deeb, L., Iotova, V., Kawamura, T., Klingensmith, G., Philotheou, A., Silverstein, J., Tumini, S., Ocampo Francisco, A., Kinduryte, O., et al. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12263 · Cited by 91
Self-citationMenstrual Cycle Effects on Insulin Sensitivity in Women with Type 1 Diabetes: A Pilot Study
Trout, K. K., Rickels, M. R., Schutta, M. H., Petrova, M., Freeman, E. W., Tkacs, N. C., & Teff, K. L. (2007) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.0004 · Cited by 75 · cited 1×
“to identify possible cyclical variation in blood glucose that might require clinician review and insulin dosage adjustment.(207,208) • It has been observed that an excessive GH secretion in type 1 dia-”
BackgroundEffects of the Anatomical Region Used for Insulin Injections on Glycemia in Type I Diabetes Subjects
Bantle, J. P., Neal, L., & Frankamp, L. M. (1993) · Diabetes Care · doi:10.2337/diacare.16.12.1592 · Cited by 70
Insulin Infusion Set Use: European Perspectives and Recommendations
Deiss, D., Adolfsson, P., Alkemade-van Zomeren, M., Bolli, G. B., Charpentier, G., Cobelli, C., Danne, T., Girelli, A., Mueller, H., Verderese, C. A., et al. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.07281.sf · Cited by 62 · cited 1×
“Thus, recommended practical tools and standardized guidelines for empowering patients to prevent, diagnose, and troubleshoot insulin infusion set failure and other problems that contribute to unexplained hyperglycemia need to employed to realize the full benefit of insulin pump therapy along the continuum of diabetes…”
Self-citationBerghaeuser, M., Kapellen, T., Heidtmann, B., Haberland, H., Klinkert, C., Holl, R., & for the DPV-Science-Initiative and the German working group for insulin pump treatment in paediatric patients (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00416.x · Cited by 58 · cited 2×
“The use of external pumps is increasing and is proving to be acceptable and successful, even in young infants.(141,142) For extensive review of CSII read Chapter 22 “Diabetes Technology” [to be published”
BackgroundKarges, B., Kapellen, T., Wagner, V. M., Steigleder-Schweiger, C., Karges, W., Holl, R. W., Rosenbauer, J., & Initiative, F. T. D. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12348 · Cited by 58
Biester, T., Blaesig, S., Remus, K., Aschemeier, B., Kordonouri, O., Granhall, C., Søndergaard, F., Kristensen, N. R., Haahr, H., & Danne, T. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12116 · Cited by 53
Self-citationEarly Detection of Infusion Set Failure During Insulin Pump Therapy in Type 1 Diabetes
Cescon, M., DeSalvo, D. J., Ly, T. T., Maahs, D. M., Messer, L. H., Buckingham, B. A., Doyle, F. J., & Dassau, E. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816663962 · Cited by 52 · cited 1×
“5 mol/L per 30 minutes).(176,177) Patients must be instructed on treatment of hyperglycemia, giving insulin with a pen or syringe in case of suspected pump failure (hyperglycemia and elevated ketone levels).”
BackgroundSelf-citationZisser, H. (2008) · Diabetes Care · doi:10.2337/dc07-1757 · Cited by 44
Cited by
Dhatariya, K. K., Glaser, N. S., Codner, E., & Umpierrez, G. E. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0165-1 · Cited by 461
Sherr, J. L., Buckingham, B. A., Forlenza, G. P., Galderisi, A., Ekhlaspour, L., Wadwa, R. P., Carria, L., Hsu, L., Berget, C., Peyser, T. A., et al. (2020) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0286 · Cited by 92
Self-citationDistinct patterns of daily glucose variability by pubertal status in youth with type 1 diabetes
Zhu, J., Volkening, L. K., & Laffel, L. M. (2020) · Diabetes Care · doi:10.2337/dc19-0083 · Cited by 30
Wadwa, R. P., Laffel, L. M., Franco, D. R., Dellva, M. A., Knights, A. W., & Pollom, R. K. (2023) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14849 · Cited by 24
“While the ISPAD guidelines recommend giving prandial insulin before meals, postmeal administration is acceptable in younger children who are at increased risk of hypoglycaemia due to unpredictable food intake and physical activity.(9) This study demonstrates that URLi can be administered after the meal if necessary wi…”
BackgroundMethodWersäll, J. H., Adolfsson, P., Forsander, G., & Hanas, R. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13377 · Cited by 21
“or insulin injection therapy (Multiple Daily Injections, MDI) are the standard options for comprehensive treatment of type 1 diabetes (T1D) in children.(1,2) Both options share the principle of basal-bolus”
Background
Metadata
- Authors
- Danne, T., Phillip, M., Buckingham, B. A., Jarosz-Chobot, P., Saboo, B., Urakami, T., Battelino, T., Hanas, R., & Codner, E.
- Venue
- Pediatric Diabetes
- Publisher
- Wiley
- Published
- 2018-10
- Volume
- 19
- Pages
- 115-135
- ISSN
- 1399-543X (ISSN-L)
- OpenAlex
- W2916889937
- Cited by
- 225
- References
- 41
- FWCI
- 18.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.